CN116832094A - Compound collateral-activating oil of lignum Dalbergiae Odoriferae - Google Patents
Compound collateral-activating oil of lignum Dalbergiae Odoriferae Download PDFInfo
- Publication number
- CN116832094A CN116832094A CN202310610941.6A CN202310610941A CN116832094A CN 116832094 A CN116832094 A CN 116832094A CN 202310610941 A CN202310610941 A CN 202310610941A CN 116832094 A CN116832094 A CN 116832094A
- Authority
- CN
- China
- Prior art keywords
- essential oil
- oil
- parts
- collateral
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 26
- 239000000341 volatile oil Substances 0.000 claims abstract description 89
- 239000003921 oil Substances 0.000 claims abstract description 35
- 239000002023 wood Substances 0.000 claims abstract description 15
- 244000178231 Rosmarinus officinalis Species 0.000 claims abstract description 13
- 240000003538 Chamaemelum nobile Species 0.000 claims abstract description 11
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims abstract description 11
- 241000208152 Geranium Species 0.000 claims abstract description 11
- 244000178870 Lavandula angustifolia Species 0.000 claims abstract description 11
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims abstract description 11
- 244000179970 Monarda didyma Species 0.000 claims abstract description 11
- 235000010672 Monarda didyma Nutrition 0.000 claims abstract description 11
- 239000001102 lavandula vera Substances 0.000 claims abstract description 11
- 235000018219 lavender Nutrition 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 239000002199 base oil Substances 0.000 claims abstract description 8
- 244000000626 Daucus carota Species 0.000 claims abstract description 6
- 235000002767 Daucus carota Nutrition 0.000 claims abstract description 6
- 244000138993 panchioli Species 0.000 claims abstract description 6
- 235000019198 oils Nutrition 0.000 claims description 34
- 244000086363 Pterocarpus indicus Species 0.000 claims description 15
- 235000009984 Pterocarpus indicus Nutrition 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims description 10
- 238000004821 distillation Methods 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 7
- 229940119170 jojoba wax Drugs 0.000 claims description 6
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 5
- 230000003213 activating effect Effects 0.000 claims description 5
- 238000000605 extraction Methods 0.000 claims description 5
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 claims description 5
- 229940032094 squalane Drugs 0.000 claims description 5
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 4
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 238000009835 boiling Methods 0.000 claims description 3
- -1 jojoba oil Chemical compound 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 17
- 208000002193 Pain Diseases 0.000 abstract description 6
- 230000036407 pain Effects 0.000 abstract description 6
- 241000196324 Embryophyta Species 0.000 abstract description 4
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 4
- 239000005556 hormone Substances 0.000 abstract description 3
- 229940088597 hormone Drugs 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract description 3
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 230000003405 preventing effect Effects 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 239000003205 fragrance Substances 0.000 description 17
- 239000000523 sample Substances 0.000 description 14
- 239000003814 drug Substances 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 240000007817 Olea europaea Species 0.000 description 4
- 239000001224 daucus carota l. seed absolute Substances 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- ZYEMGPIYFIJGTP-UHFFFAOYSA-N O-methyleugenol Chemical compound COC1=CC=C(CC=C)C=C1OC ZYEMGPIYFIJGTP-UHFFFAOYSA-N 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000003020 moisturizing effect Effects 0.000 description 2
- 208000013465 muscle pain Diseases 0.000 description 2
- 230000037307 sensitive skin Effects 0.000 description 2
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 1
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 241000402754 Erythranthe moschata Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 240000004153 Hibiscus sabdariffa Species 0.000 description 1
- 235000001018 Hibiscus sabdariffa Nutrition 0.000 description 1
- 244000018716 Impatiens biflora Species 0.000 description 1
- 206010065390 Inflammatory pain Diseases 0.000 description 1
- 206010049816 Muscle tightness Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 206010036618 Premenstrual syndrome Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940116837 methyleugenol Drugs 0.000 description 1
- PRHTXAOWJQTLBO-UHFFFAOYSA-N methyleugenol Natural products COC1=CC=C(C(C)=C)C=C1OC PRHTXAOWJQTLBO-UHFFFAOYSA-N 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000010669 rosewood oil Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a compound collateral-activating oil of dalbergia wood, which belongs to the technical field of health products and comprises the following raw materials in parts by weight: 2 to 5 parts of lobular de-true essential oil, 1 to 3 parts of bergamot essential oil, 0.5 to 1 part of lavender essential oil, 0.2 to 0.5 part of geranium essential oil, 0.2 to 0.5 part of carrot seed essential oil, 0.1 to 0.5 part of rosemary essential oil, 0.1 to 0.5 part of roman chamomile essential oil and 70 to 90 parts of base oil. The invention combines the lobular anti-inflammatory essential oil with various herbal traditional Chinese medicines and pure natural plant essential oil, does not contain any hormone substances, has the effects of fast pain relieving, swelling preventing, antibacterial and anti-inflammatory, has relatively comprehensive effects and has good use effect.
Description
Technical Field
The invention belongs to the technical field of health products, and particularly relates to a compound collateral-activating oil of dalbergia wood.
Background
Lignum Dalbergiae Odoriferae (foreign name: agarattan), respectively: reducing blood pressure, lowering blood lipid, lowering blood sugar, lowering blood pressure, belongs to the genus Pterocarpus of the family Leguminosae (Papilionaceae), and comprises two kinds of lignum Dalbergiae Odoriferae and lignum Dalbergiae Odoriferae. The rosewood oil is rich in oil and has fresh and strong fragrance, and mainly has flower fragrance, honey fragrance, musk, orchid fragrance, rosewood fragrance, fruit fragrance, frankincense, medicinal fragrance and the like, and has the theory of one rattan and eight fragrances. The big leaves and the small leaves She Zi are the same family of plants, the big leaves are floral, the small leaves are coconut, and the big leaves and the small leaves are rosewood. The records and application history of the dual-purpose of the rosewood fragrance and the medicine are related in ancient and modern times and the rosewood fragrance has higher potential economic value and application prospect of the dual-purpose of the fragrance and the medicine. Modern medical research proves that the essential oil has three main effects: the elemene has the functions of relieving pain, resisting virus, sterilizing and treating wounds and balsam; secondly, the methyl eugenol has the functions of anesthesia, analgesia, antipyresis and anti-inflammatory; thirdly, the extract contains as many as 23 flavonoid components, has strong functions of resisting oxidization, diminishing inflammation, easing pain, relaxing blood vessels, improving blood circulation, strengthening tendons and bones, delaying aging, resisting tumors, moisturizing skin, removing spots and the like, and also has good repairing function on oxidative damage of nerve cells.
The traditional Chinese medicine oil is a medicinal oil which is developed based on the characteristics of the traditional Chinese medicine and combines the advantages of the production process and the medicinal effect of the traditional Chinese medicine, is used on the surface of the skin, and plays a certain role in treating the skin or the channels. However, the traditional Chinese medicine oil has poor use experience and unpleasant smell. The aromatic essential oil preparation has pleasant smell, and has better experience and skin moistening effect than traditional Chinese medicine oil. The rosewood heart wood has good smell and has the effects of easing pain and resisting inflammation, but the existing essential oil for reducing the blood fat in the market is mostly single essential oil, the effect is single, and when the rosewood heart wood is used, other Chinese medicinal essential oil with coordination and synergy is needed to be additionally added to exert larger and better efficacy.
Disclosure of Invention
In view of the above, the invention provides a compound collateral-activating oil of lignum Dalbergiae Odoriferae, which is prepared by compounding the essential oil of lignum Dalbergiae Odoriferae with various herbal medicines and pure natural plant essential oil, does not contain any hormone substances, has the effects of fast pain relieving, swelling preventing, antibacterial and anti-inflammatory, has relatively comprehensive effects and has good use effect.
The invention is realized by the following technical scheme:
the rosewood heart wood compound collateral-activating oil comprises the following raw materials in parts by weight: 2 to 5 parts of lobular de-true essential oil, 1 to 3 parts of bergamot essential oil, 0.5 to 1 part of lavender essential oil, 0.2 to 0.5 part of geranium essential oil, 0.2 to 0.5 part of carrot seed essential oil, 0.1 to 0.5 part of rosemary essential oil, 0.1 to 0.5 part of roman chamomile essential oil and 70 to 90 parts of base oil.
Further, the base oil is composed of light squalane, olive oil, jojoba oil, and tocopheryl acetate.
Further, the preparation process of the leaflet de-trueness essential oil comprises the following steps:
s1: weighing lignum Dalbergiae Odoriferae log, pulverizing, and sieving to obtain powder sample;
s2: and carrying out normal pressure distillation extraction on the powder sample, and then standing for layering to obtain the leaflet anti-true essential oil.
Further, in step S2, the powder sample is mixed with water and put into a simultaneous distillation extractor for atmospheric distillation extraction.
Further, in step S2, the ratio of the powder sample to water is 1:8.
Further, in step S2, the powder sample was kept boiling at 100 ℃ for 5 hours under normal pressure.
Compared with the prior art, the invention has the following technical effects:
the invention prepares the roselle essential oil, bergamot essential oil, lavender essential oil, geranium essential oil, carrot seed essential oil, rosemary essential oil and roman chamomile essential oil into a compound, and uses vegetable source grease such as olive fruit oil, jojoba oil, vitamin E and the like as base oil for dilution. The essential oils exert the effects and have synergistic effect, and the bergamot essential oil can improve dry, oily and sensitive skin and treat inflammation and eczema; the lavender essential oil can promote cell regeneration and wound healing, and can be used for treating various wounds such as burn, sunburn and the like; the geranium essential oil can promote blood circulation and improve symptoms such as water retention, swelling and the like; regulating hormone secretion, relaxing muscles, improving premenstrual syndrome and climacteric emotion; the rosemary essential oil can astringe skin and has a tightening effect; the roma chamomile essential oil can improve rough skin, dry skin, easy occurrence of acne and the like; relieving sensitive skin and repairing microvascular.
The components of the selected formula of the invention are herbal traditional Chinese medicines and purely natural plants, the essential oil is easy to enter human bodies due to the natural characteristics and small molecules, the compatibility of the medicines is scientific, the preparation process is reasonable, the effective components of the traditional Chinese medicine raw materials are not destroyed, the invention has no toxic or side effect, no addiction and no drug resistance, and the invention has obvious effects on various pains, especially inflammatory pains.
Drawings
FIG. 1 is a flow chart showing the extraction of lignum Dalbergiae Odoriferae in example 1 of the present invention.
Detailed Description
The present invention will be described in further detail with reference to specific embodiments in order to make the objects, technical solutions and advantages of the present invention more apparent. It should be understood that the specific embodiments described herein are for purposes of illustration only and are not intended to limit the scope of the invention. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
In the following examples, the following equipments and materials were used:
TABLE 1 apparatus to which the invention relates
| Sequence number | Device name | Model specification |
| 1 | Distillation apparatus | Laboratory roomAssembly |
| 2 | Electronic balance | SHINKO G323 |
| 3 | Constant temperature box | Shanghai BoXun BIC-300 |
The materials used were as follows:
the lobule rosewood log: commercially available inclined She Huangtan
Bergamot essential oil: atdi fragrance (Guangzhou Co., ltd.)
Lavender essential oil: atdi fragrance (Guangzhou Co., ltd.)
Geranium essential oil: atdi fragrance (Guangzhou Co., ltd.)
Carrot seed oil: atdi fragrance (Guangzhou Co., ltd.)
Rosemary essential oil: atdi fragrance (Guangzhou Co., ltd.)
Romaine chamomile essential oil: atdi fragrance (Guangzhou Co., ltd.)
Example 1
The embodiment provides a rosewood heart wood compound collateral-activating oil which comprises the following raw materials in parts by weight: 5 parts of lobular essential oil, 2 parts of bergamot essential oil, 0.75 part of lavender essential oil, 0.35 part of geranium essential oil, 0.35 part of carrot seed oil, 0.3 part of rosemary essential oil, 0.35 part of roman chamomile essential oil, 26 parts of light squalane, 28 parts of olive fruit oil, 18 parts of jojoba oil and 8 parts of tocopherol acetate.
As shown in fig. 1, the preparation process of the leaflet anti-inflammation essential oil specifically comprises the following steps:
s1: weighing 200g of dried log of lignum Dalbergiae Odoriferae with small leaves on an electronic balance, pulverizing, and sieving with a 40-mesh sieve to obtain a powder sample;
s2: placing the powder sample in a round bottom flask of a simultaneous distillation extractor, adding 1600g of distilled water according to a feed liquid ratio of 1:8, soaking for 6 hours, and then boiling and distilling for 5 hours at 100 ℃ under normal pressure to extract volatile components of dalbergia wood;
s3: distilling the sample, standing for layering, and separating oil from water to obtain the essential oil.
The components are added and mixed according to the sequence of the addition amount from large to small, and the compound activating oil is prepared.
Example 2
The embodiment provides a rosewood heart wood compound collateral-activating oil which comprises the following raw materials in parts by weight: 3.5 parts of lobular essential oil, 3 parts of bergamot essential oil, 0.75 part of lavender essential oil, 0.35 part of geranium essential oil, 0.35 part of carrot seed oil, 0.3 part of rosemary essential oil, 0.35 part of Roman chamomile, 26 parts of light squalane, 28 parts of olive fruit oil, 18 parts of jojoba oil and 8 parts of tocopheryl acetate.
The preparation process of the leaflet anti-aliasing essential oil is shown in the example 1.
The raw materials are added and mixed according to the sequence of the addition amount from large to small, and the compound collateral activating oil is prepared.
Example 3
The embodiment provides a rosewood heart wood compound collateral-activating oil which comprises the following raw materials in parts by weight: 3.5 parts of lobular essential oil, 2 parts of bergamot essential oil, 1 part of lavender essential oil, 0.35 part of geranium essential oil, 0.35 part of carrot seed oil, 0.3 part of rosemary essential oil, 0.35 part of roman chamomile, 26 parts of light squalane, 28 parts of olive fruit oil, 18 parts of jojoba oil and 8 parts of tocopheryl acetate.
The preparation process of the leaflet anti-aliasing essential oil is shown in the example 1.
The raw materials are added and mixed according to the sequence of the addition amount from large to small, and the compound collateral activating oil is prepared.
Efficacy tests were performed on compound collateral-activating oils of examples 1-3:
test principle: the adhesive tape made of biological materials such as the simulated stratum corneum and the epidermis simulates the process of smearing cosmetics on human skin, has strong binding force to moisture, and shows good hygroscopicity and moisture retention; good sealing performance, less water loss and strong moisture retention.
The test method comprises the following steps: a piece of 3M bionic adhesive tape with the length of 4.8cm multiplied by 4.8cm is adhered to a glass plate with the length of 5cm multiplied by 5cm to serve as a carrier, 50mg of sample is uniformly smeared on the carrier, the weight of the sample is obtained by weighing, then the sample is placed in a constant temperature and humidity environment for 3 hours, the weight change of the sample is tested, and the moisture absorption rate and the water loss rate are calculated. The test results are shown in Table 2 below.
TABLE 2 test results of Compound collateral-activating oil of example 1
As can be seen from table 2, the comparison of the moisture absorption rate/water loss rate at each stage between the control and the reference sample is considered as follows: the moisture absorption rate of the test object is reduced, the moisture absorption rate of the control is increased, and the moisture absorption rate of the test object is larger than that of the control and has moisture absorption property after 0-6 h; 6-9 hours, the water loss rate of the test object is smaller than that of the control object, and the moisture retention property is achieved; the data from 9 to 24 hours show that the test sample of example 1 has a certain moisturizing effect due to the weak hygroscopicity of the test sample after the water loss stage.
In addition, 60 users with insensitive skin with shoulder and neck, lumbar muscle and joint pain problems or other stiffness problems are selected, trial reactions are carried out on the compound collateral-activating oil effects of the embodiments 1-3, each person trial two products, the two products are respectively used at different positions (twice a day) and are left for 2 weeks, the collection user experience summarization shows that the compound collateral-activating oil prepared in the embodiments 1-3 has the effects of relieving muscle and joint pain, relieving muscle tension stiffness, relaxing emotion, moistening skin and the like. Overall, the user's overall satisfaction with the compound activating oil of example 1 was highest, example 3 being next.
In summary, the invention prepares the rosemary essential oil, the bergamot essential oil, the lavender essential oil, the geranium essential oil, the carrot seed essential oil, the rosemary essential oil, the roman chamomile essential oil and the base oil into a compound, can solve the problem of single function of the rosemary essential oil, provides a reference for the traditional medicine oil, provides an innovative scheme, gives consideration to the experience and the efficacy of the medicine oil, inherits and develops the traditional prescription, and promotes the application and popularization of natural components such as essential oil.
The above description is only a few examples of the present invention and is not intended to limit the embodiments and the protection scope of the present invention, and it should be appreciated by those skilled in the art that equivalent substitutions and obvious changes made by the content of the present invention should be included in the protection scope of the present invention.
Claims (7)
1. The rosewood heart wood compound collateral-activating oil is characterized by comprising the following raw materials in parts by weight: 2 to 5 parts of lobular de-true essential oil, 1 to 3 parts of bergamot essential oil, 0.5 to 1 part of lavender essential oil, 0.2 to 0.5 part of geranium essential oil, 0.2 to 0.5 part of carrot seed essential oil, 0.1 to 0.5 part of rosemary essential oil, 0.1 to 0.5 part of roman chamomile essential oil and 70 to 90 parts of base oil.
2. The rosewood heart wood compound collateral-activating oil according to claim 1, which is characterized by comprising the following raw materials in parts by weight: the essential oil comprises, by weight, 5 parts of lobular essential oil, 2 parts of bergamot essential oil, 0.75 part of lavender essential oil, 0.35 part of geranium essential oil, 0.35 part of carrot seed essential oil, 0.3 part of rosemary essential oil, 0.35 part of Roman chamomile and 80 parts of base oil.
3. The rosewood heart wood compound collateral activating oil of claim 2, wherein said base oil is composed of light squalane, olive oil, jojoba oil, and tocopheryl acetate.
4. The compound dalbergia wood collateral-activating oil of claim 1, wherein the preparation process of the dalbergia wood essential oil comprises the following steps:
s1: weighing lignum Dalbergiae Odoriferae log, pulverizing, and sieving to obtain powder sample;
s2: and carrying out normal pressure distillation extraction on the powder sample, and then standing for layering to obtain the leaflet anti-true essential oil.
5. The compound collateral-activating oil of lignum Dalbergiae Odoriferae of claim 4, wherein in step S2, the powder sample is mixed with water and extracted by distillation under normal pressure in a simultaneous distillation and extraction instrument.
6. The compound dalbergia wood collateral-activating oil of claim 5, wherein in step S2, the ratio of the powder sample to water is 1:8.
7. The compound collateral-activating oil of lignum Dalbergiae Odoriferae of claim 4, wherein in step S2, the powder sample is kept boiling at 100deg.C for 5 hr under normal pressure.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310610941.6A CN116832094A (en) | 2023-05-26 | 2023-05-26 | Compound collateral-activating oil of lignum Dalbergiae Odoriferae |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310610941.6A CN116832094A (en) | 2023-05-26 | 2023-05-26 | Compound collateral-activating oil of lignum Dalbergiae Odoriferae |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116832094A true CN116832094A (en) | 2023-10-03 |
Family
ID=88162503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310610941.6A Pending CN116832094A (en) | 2023-05-26 | 2023-05-26 | Compound collateral-activating oil of lignum Dalbergiae Odoriferae |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116832094A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005023044A (en) * | 2003-07-04 | 2005-01-27 | Nitto Yakuhin Kogyo Kk | Aromatic agent |
| CN109330919A (en) * | 2018-11-22 | 2019-02-15 | 黄岳娇 | A kind of multi-functional pro-skin compound essential oil |
| CN110624031A (en) * | 2019-09-26 | 2019-12-31 | 广西鹤兰墨生物科技有限公司 | Essential oil for lowering essence, nourishing meridian and health care |
-
2023
- 2023-05-26 CN CN202310610941.6A patent/CN116832094A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005023044A (en) * | 2003-07-04 | 2005-01-27 | Nitto Yakuhin Kogyo Kk | Aromatic agent |
| CN109330919A (en) * | 2018-11-22 | 2019-02-15 | 黄岳娇 | A kind of multi-functional pro-skin compound essential oil |
| CN110624031A (en) * | 2019-09-26 | 2019-12-31 | 广西鹤兰墨生物科技有限公司 | Essential oil for lowering essence, nourishing meridian and health care |
Non-Patent Citations (1)
| Title |
|---|
| 冯嘉文;王普兵;杨晓珊;: "精油论述", 广东化工, no. 03, 15 February 2020 (2020-02-15), pages 107 - 108 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Abelan et al. | Potential use of essential oils in cosmetic and dermatological hair products: A review | |
| Kizhedath et al. | Estimation of chlorophyll content in common household medicinal leaves and their utilization to avail health benefits of chlorophyll | |
| CN107174552B (en) | Willow flower extract and preparation method and application thereof | |
| CN108113914A (en) | A kind of essence cream for not adding essence preservative and preparation method thereof | |
| CN106727168A (en) | With skin care compositions for repairing sensitive skin effect and its preparation method and application | |
| Maramaldi et al. | Anti-inflammaging and antiglycation activity of a novel botanical ingredient from African biodiversity (Centevita™) | |
| CN109055048A (en) | A kind of pure natural moisturizing anti-acne handmade soap and its preparation method and application | |
| KR20150045049A (en) | Cosmetic composition for skin moisturizing comprising plant extracts and preparation method thereof | |
| CN107126388A (en) | A kind of anti-oxidant Face-protecting mask | |
| KR20220168132A (en) | Composition for skin containing pine bark extract having edema relief, cellulite reduction and whitening effects, and skin cream using the same | |
| CN109498523A (en) | The anti-chap skin care item of one kind and its preparation | |
| WO2001005416A1 (en) | Oil from momordica charantia l., its method of preparation and uses | |
| CN113274319A (en) | After-sun soothing, repairing and brightening skin care composition, preparation method and application | |
| KR20200029289A (en) | Cosmetic composition with skin soothing effect comprising mushroom complex extract, and manufacturing method thereof | |
| KR102062230B1 (en) | Cosmetic composition with skin soothing effect comprising vitamin tree extract, and manufacturing method thereof | |
| KR101459742B1 (en) | Cosmetic composition for improving acne containing extracts of natural substance | |
| CN104188859A (en) | Anti-wrinkle skin-tendering emulsion containing natural component extracts and preparation method thereof | |
| CN116832094A (en) | Compound collateral-activating oil of lignum Dalbergiae Odoriferae | |
| KR100905437B1 (en) | Composition for treating of atopic dermatitis and preparing method thereof | |
| JP2014221739A (en) | Type vii collagen expression promoter | |
| CN102872240A (en) | Compound essential oil for relaxing and activating collaterals | |
| Vartak et al. | Medicinal and Aromatic Plants in the Cosmetics Industry | |
| Tabatabaei et al. | The effect of sesame oil and cucurbita on healing wounds caused by third-degree burn | |
| CN110538115A (en) | Composition with effects of moisturizing and lip repairing as well as preparation method and application thereof | |
| KR20170047515A (en) | Skin vital rising cosmetic composition comprising Graviola antibiotic extract and method of preparing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |